Smith v. Bayer Corp.

Background

Two plaintiffs sued Bayer over an allegedly dangerous prescription drug called Baycol. George McCollins sued first in West Virginia state court, sought class certification, and his case was removed to federal court and consolidated in a multi-district proceeding. Keith Smith later sued in a different West Virginia county and sought class certification there; his case stayed in state court. The federal judge denied class certification in McCollins’ suit under Federal Rule 23 and dismissed his claims; McCollins did not appeal. Bayer then asked that same federal judge to enjoin the state court from considering Smith’s certification motion. The federal court granted the injunction, and the Eighth Circuit affirmed.

Reasoning

The Court examined whether the Anti-Injunction Act’s narrow relitigation exception allowed the federal order. That exception permits a federal court to stop state proceedings only when necessary to protect a federal judgment, and only when the same issue was previously decided and the person to be bound was actually a party or fit a narrow exception. The Court found both requirements unmet. West Virginia’s approach to its class rule (as shown in In re Rezulin) differed from the federal court’s analysis, so the issues were not identical. And because McCollins’ proposed class was never certified, Smith—an unnamed, uncertified class member—was not a party and could not be bound by the federal ruling. The injunction therefore exceeded federal authority.

Real world impact

The Court reversed the injunction, leaving state courts free to decide class-certification questions and limiting federal courts’ power to block those proceedings. The decision reinforces that injunctions under the relitigation exception are rare and that uncertified class members are not bound by earlier federal rulings.